Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis

Zhang W, Dong X, Huang R.

Pharmacol Res. 2023 Jul;193:106787. doi: 10.1016/j.phrs.2023.106787. Epub 2023 May 22.

Role of Deubiquitinases in Parkinson's Disease-Therapeutic Perspectives

Nielsen PYØ, Okarmus J, Meyer M.

Cells. 2023 Feb 17;12(4):651. doi: 10.3390/cells12040651.

Inflammasome assembly in neurodegenerative diseases

Singh J, Habean ML, Panicker N.

Trends Neurosci. 2023 Oct;46(10):814-831. doi: 10.1016/j.tins.2023.07.009. Epub 2023 Aug 24.

Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View

Sanghai N, Tranmer GK.

Cells. 2023 Sep 20;12(18):2318. doi: 10.3390/cells12182318.

Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action

Rinaldi D, Alborghetti M, Bianchini E, Sforza M, Galli S, Pontieri FE.

Curr Neuropharmacol. 2023;21(5):1214-1223. doi: 10.2174/1570159X20666220905102144.

Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings

Zamanian MY, Terefe EM, Taheri N, Kujawska M, Tork YJ, Abdelbasset WK, Shoukat S, Opulencia MJC, Heidari M, Alesaeidi S.

CNS Neurol Disord Drug Targets. 2023;22(10):1453-1461. doi: 10.2174/1871527322666221005122408.

The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson's Disease in Zebrafish: The Current Applications and Perspectives

Abidar S, Hritcu L, Nhiri M.

CNS Neurol Disord Drug Targets. 2023;22(10):1472-1483. doi: 10.2174/1871527322666221028152600.

Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better?

Bayram E, Batzu L, Tilley B, Gandhi R, Jagota P, Biundo R, Garon M, Prasertpan T, Lazcano-Ocampo C, Chaudhuri KR, Weil RS; International Parkinson and Movement Disorder Society Non-Motor Parkinson's Disease Study Group.

Parkinsonism Relat Disord. 2023 Jul;112:105385. doi: 10.1016/j.parkreldis.2023.105385. Epub 2023 Mar 29.

Machine learning for adaptive deep brain stimulation in Parkinson's disease: closing the loop

Oliveira AM, Coelho L, Carvalho E, Ferreira-Pinto MJ, Vaz R, Aguiar P.

J Neurol. 2023 Nov;270(11):5313-5326. doi: 10.1007/s00415-023-11873-1. Epub 2023 Aug 2.

The multimodal effect of circadian interventions in Parkinson's disease: A narrative review

Smilowska K, van Wamelen DJ, Bloem BR.

Parkinsonism Relat Disord. 2023 May;110:105309. doi: 10.1016/j.parkreldis.2023.105309. Epub 2023 Feb 2.

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson's Disease: An Updated Review

Angelopoulou E, Stanitsa E, Karpodini CC, Bougea A, Kontaxopoulou D, Fragkiadaki S, Koros C, Georgakopoulou VE, Fotakopoulos G, Koutedakis Y, Piperi C, Papageorgiou SG.

Medicina (Kaunas). 2023 Aug 12;59(8):1454. doi: 10.3390/medicina59081454.

Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment

Kalsoom I, Wang Y, Li B, Wen H.

Mini Rev Med Chem. 2023;23(20):1959-1974. doi: 10.2174/1389557523666230517163501.

Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration

Mittal P, Goyal R, Kapoor R, Wan C, Gautam RK.

Curr Neuropharmacol. 2023;21(4):777-786. doi: 10.2174/1570159X21666230220102605.

Redox Imbalance in Neurological Disorders in Adults and Children

Rey F, Berardo C, Maghraby E, Mauri A, Messa L, Esposito L, Casili G, Ottolenghi S, Bonaventura E, Cuzzocrea S, Zuccotti G, Tonduti D, Esposito E, Paterniti I, Cereda C, Carelli S.

Antioxidants (Basel). 2023 Apr 20;12(4):965. doi: 10.3390/antiox12040965.

Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases

Braga SS.

Biomolecules. 2023 Apr 12;13(4):666. doi: 10.3390/biom13040666.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias